Patents by Inventor Johannes van der Vies

Johannes van der Vies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4220599
    Abstract: The invention relates to an oral pharmaceutical preparation with androgenic activity on the basis of one or more esters of testosterone and/or 5.alpha.-dihydrotestosterone, the ester group of which has been derived exclusively from aliphatic carboxylic acids having 9-16 carbon atoms, preferably 10-12 carbon atoms in combination with a non-steroidal lipoid. The preparation may additionally contain a progestational steroid, an oestrogen or a precursor of an A-aromatic steroid.
    Type: Grant
    Filed: November 2, 1978
    Date of Patent: September 2, 1980
    Assignee: Akzona Incorporated
    Inventor: Johannes van der Vies
  • Patent number: 4147783
    Abstract: The invention relates to an oral pharmaceutical preparation with androgenic activity on the basis of one or more esters of testosterone and/or 5.alpha.-dihydrotestosterone, the ester group of which has been derived exclusively from aliphatic carboxylic acids having 9-16 carbon atoms, preferably 10-12 carbon atoms in combination with a non-steroidal lipoid. The preparation may additionally contain a progestational steroid, an oestrogen or a precursor of an A-aromatic steroid.
    Type: Grant
    Filed: November 10, 1977
    Date of Patent: April 3, 1979
    Assignee: Akzona Incorporated
    Inventor: Johannes van der Vies
  • Patent number: 4098802
    Abstract: The invention relates to an oral pharmaceutical preparation with androgenic activity on the basis of one or more esters of testosterone and/or 5.alpha.-dihydrotestosterone, the ester group of which has been derived exclusively from aliphatic carboxylic acids having 9-16 carbon atoms, preferably 10-12 carbon atoms in combination with a non-steroidal lipoid. The preparation may additionally contain a progestational steroid, an oestrogen or a precursor of an A-aromatic steroid.
    Type: Grant
    Filed: May 28, 1976
    Date of Patent: July 4, 1978
    Assignee: Akzona Incorporated
    Inventor: Johannes van der Vies
  • Patent number: 4083973
    Abstract: The invention relates to a novel pharmaceutical preparation with anabolic activity adapted for oral administration comprising a nandrolone (= 19-nor-testosterone)-17.beta.-ester, the ester group of which has been derived from aliphatic carboxylic acids having 9-18 carbon atoms, in combination with a non-steroidal lipoid. The preparation may additionally contain a mineralocorticoid steroid. The invention also relates to novel nandrolone-17.beta.-esters.
    Type: Grant
    Filed: August 16, 1976
    Date of Patent: April 11, 1978
    Assignee: Akzona Incorporated
    Inventor: Johannes van der Vies
  • Patent number: 4071623
    Abstract: The invention relates to a novel pharmaceutical preparation with oestrogenic activity adapted for oral administration comprising an oestradiol-17.beta.-ester, the ester group of which has been derived from aliphatic carboxylic acids having 9-16 carbon atoms, in combination with a non-steroidal lipoid. The preparation may additionally contain a progestational steroid or an androgen. The invention also relates to novel oestradiol-17.beta.-esters.
    Type: Grant
    Filed: May 17, 1976
    Date of Patent: January 31, 1978
    Assignee: Akzona Incorporated
    Inventor: Johannes van der Vies
  • Patent number: 4002747
    Abstract: The invention relates to a novel di-ester of 19-nor-testosterone and the preparation thereof. The novel di-ester, i.e. the 2',2" -oxydiacetate, is a strong anabolic agent.
    Type: Grant
    Filed: November 24, 1975
    Date of Patent: January 11, 1977
    Assignee: Akzona Incorporated
    Inventor: Johannes van der Vies